U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. PepsiCo, Inc. - 679972 - 09/10/2024
  1. Warning Letters

CLOSEOUT LETTER

PepsiCo, Inc. MARCS-CMS 679972 —

Delivery Method:
VIA Electronic Mail
Product:
Food & Beverages
Recipient:
Recipient Name
Ramon Laquarta
Recipient Title
CEO
PepsiCo, Inc.
The Quaker Oats Co.

700 Anderson Hill Road
Purchase, NY 10577
United States

Ramon.laguarta@pepsico.com
Issuing Office:
Division of Human and Animal Food Operations East VI

United States

Secondary Issuing Offices

United States

Dear Mr. Laquarta:

The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter (CMS#679972), dated June 12, 2024. Based on our evaluation, it appears that you have addressed the violation(s) by permanently closing your Danville, IL facility. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of corrections at all locations.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
LCDR Audrey DeLa Cruz
Acting, Director of Compliance
Office of Human and Animal Food
Division HAFE6

Back to Top